Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024
Compare Profit and Loss Results of Bajaj Healthcare
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
542.00
359.00
183.00
50.97%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
542.00
359.00
183.00
50.97%
Expenditure (Ex Depriciation)
Stock Adjustments
-20.00
1.00
-21.00
-2,100.00%
Raw Materials Consumed
307.00
183.00
124.00
67.76%
Power & Fuel Cost
22.00
20.00
2.00
10.00%
Employee Cost
57.00
50.00
7.00
14.00%
Operating Expenses
63.00
55.00
8.00
14.55%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
3.00
3.00
100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
6.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
460.00
332.00
128.00
38.55%
Operating Profit (PBDIT) excl Other Income
82.00
26.00
56.00
215.38%
Other Income
19.00
9.00
10.00
111.11%
Operating Profit (PBDIT)
101.00
36.00
65.00
180.56%
Interest
27.00
3.00
24.00
800.00%
Profit before Depriciation and Tax
73.00
33.00
40.00
121.21%
Depreciation
27.00
9.00
18.00
200.00%
Profit Before Taxation & Exceptional Items
46.00
23.00
23.00
100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
46.00
23.00
23.00
100.00%
Provision for Tax
3.00
5.00
-2.00
-40.00%
Profit After Tax
42.00
18.00
24.00
133.33%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
267.00
257.00
10.00
3.89%
Profit Available for appropriations
310.00
275.00
35.00
12.73%
Appropriations
310.00
275.00
35.00
12.73%
Equity Dividend (%)
20%
35%
-15.00
Earnings Per Share
13.29
29.35
-16.06
-54.72%
Profit And Loss - Net Sales
Net Sales 542.60 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 82.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024
Profit And Loss - Interest
Interest 27.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 42.93 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024
